Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
The overall goal of this study is to correlate the host and viral genetics of patients infected with viral hepatitis with their clinical presentation. This study will provide the first nation-wide estimate of key host genetic polymorphisms associated with immune response, such as in the IL28B gene locus which has been associated with treatment outcomes in hepatitis C. Characterization of HCV and HBV viral genotypes and sub-types across different geographic regions will allow for an exploration of associations between host and viral genotypes. Another objective of this study is to identify co-morbid illness and metabolic factors that are associated with chronic liver disease due to viral hepatitis. Finally, this survey will explore patient awareness of their disease, risk factors for disease progression, and their treatment options
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Willing and able to provide written informed consent
Male or female, age \>= 18
Willing and able to comply with the visit procedure
Prior diagnosis of chronic HCV infection or chronic HBV infection
You may not be if
History of difficulty with blood collection and/or poor venous access for the purposes of phlebotomy
History of bleeding disorder
Blood loss requiring transfusion or \> 3 g/dL decrease in hemoglobin within 4 days of the visit
Knowingly co-infected with HCV/HBV or with HIV
Currently undergoing therapy for chronic hepatitis C or chronic hepatitis B
Currently receiving treatment with any other investigational agent or device -- Enrolled in another clinical study evaluating a treatment or procedure